Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

ETON

Eton Pharmaceuticals Inc

Oct 07 • 02:05PM ET

7.29

Dollar change +0.29
Percentage change 4.14	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Held by: VTI VXF IWC DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	5.31%	Shs Outstand	25.69M	Perf Week	21.50%
Market Cap	188.37M	Forward P/E	18.22	EPS next Y	0.40	Insider Trans	8.50%	Shs Float	24.46M	Perf Month	58.82%
Income	-6.69M	PEG	-	EPS next Q	-0.01	Inst Own	33.40%	Short Float	0.31%	Perf Quarter	112.54%
Sales	31.38M	P/S	6.00	EPS this Y	-300.00%	Inst Trans	34.01%	Short Ratio	0.70	Perf Half Y	111.30%
Book/sh	0.52	P/B	13.94	EPS next Y	350.00%	ROA	-21.31%	Short Interest	0.08M	Perf Year	82.25%
Cash/sh	0.68	P/C	10.65	EPS next 5Y	-	ROE	-44.30%	52W Range	3.03 - 7.07	Perf YTD	66.44%
Dividend Est.	-	P/FCF	6279.12	EPS past 5Y	63.71%	ROI	-49.14%	52W High	3.11%	Beta	1.30
Dividend TTM	-	Quick Ratio	1.28	Sales past 5Y	11165.96%	Gross Margin	59.48%	52W Low	140.59%	ATR (14)	0.37
Dividend Ex-Date	-	Current Ratio	1.40	EPS Y/Y TTM	-2445.10%	Oper. Margin	-20.00%	RSI (14)	83.35	Volatility	8.03% 6.17%
Employees	30	Debt/Eq	0.36	Sales Y/Y TTM	8.14%	Profit Margin	-21.31%	Recom	1.00	Target Price	10.50
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-167.24%	Payout	-	Rel Volume	3.73	Prev Close	7.00
Sales Surprise	3.11%	EPS Surprise	-71.43%	Sales Q/Q	-24.36%	Earnings	Aug 08 AMC	Avg Volume	107.45K	Price	7.29
SMA20	28.97%	SMA50	55.55%	SMA200	77.89%	Trades		Volume	288,179	Change	4.14%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-04-24	Resumed	H.C. Wainwright	Buy	$9
May-06-24	Initiated	Craig Hallum	Buy	$8
Oct-14-21	Resumed	B. Riley Securities	Buy	$10
Jan-04-21	Reiterated	H.C. Wainwright	Buy	$20 → $15
Sep-20-19	Initiated	B. Riley FBR	Buy	$13.50
Jun-10-19	Initiated	H.C. Wainwright	Buy	$15

Oct-03-24 06:30AM	Eton Pharmaceuticals, Inc to Acquire Increlex (mecasermin injection) from Ipsen (GlobeNewswire) +16.33%
Sep-13-24 02:22AM	Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc. (GuruFocus.com) +6.85%
Aug-22-24 04:30PM	Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) +6.82%
Aug-08-24 09:59PM	ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:01PM	Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results (GlobeNewswire)
05:30PM	Loading…
Jul-30-24 05:30PM	Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (ACCESSWIRE)
Jul-15-24 04:05PM	Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) (GlobeNewswire) +7.49%
May-10-24 10:11AM	Q1 2024 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 04:01PM	Eton Pharmaceuticals Reports First Quarter 2024 Financial Results (GlobeNewswire) -7.66%
May-01-24 04:05PM	Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference (GlobeNewswire) +5.14%
Apr-30-24 11:21AM	Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400 (MT Newswires)
07:00AM	Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) (GlobeNewswire)
Apr-29-24 04:30PM	Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (GlobeNewswire)
Mar-22-24 02:20AM	Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE (ACCESSWIRE) +9.39%
02:00AM	Loading…
02:00AM	Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE for Phenylketonuria (GlobeNewswire)
Mar-15-24 03:10PM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript (Insider Monkey) -13.68%
09:34AM	Q4 2023 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:35PM	Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ... (GuruFocus.com)
05:15PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-29-24 04:01PM	Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 (GlobeNewswire)
Feb-26-24 08:19AM	Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-21-24 06:50AM	Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation (GlobeNewswire)
Feb-02-24 06:50AM	Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules (GlobeNewswire)
Jan-16-24 07:52AM	3 Pharma Stocks for January 2024 Profits (Entrepreneur: Stocks) -6.41%
Nov-11-23 11:09AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:01PM	Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results (GlobeNewswire) -15.23%
Oct-30-23 06:50AM	Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (GlobeNewswire)
05:16AM	Loading…
Oct-23-23 05:16AM	Eton Pharma (ETON) to Report Q3 Earnings: What's in the Cards? (Zacks)
Oct-18-23 08:00AM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (PR Newswire)
Oct-04-23 06:50AM	Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone (GlobeNewswire)
Sep-22-23 12:04PM	Immix (IMMX) Up on Orphan Drug Tag for AL Amyloidosis Therapy (Zacks)
Sep-20-23 09:40AM	Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-12-23 08:50AM	Here's Why 'Trend' Investors Would Love Betting on Eton Pharmaceuticals, Inc. (ETON) (Zacks)
Aug-25-23 11:36AM	Eton Pharmaceuticals (ETON): A Modestly Undervalued Stock Worth Your Attention (GuruFocus.com)
Aug-23-23 06:50AM	Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-16-23 09:15AM	Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run? (Zacks) -8.44%
Aug-13-23 07:52AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 12:44PM	Q2 2023 Eton Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +38.08%
Aug-10-23 05:40PM	Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-08-23 10:50AM	Techne (TECH) Meets Q4 Earnings Estimates (Zacks)
Aug-01-23 04:05PM	Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023 (GlobeNewswire)
Jul-17-23 04:05PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (PR Newswire)
Jul-15-23 08:40AM	The past three years for Eton Pharmaceuticals (NASDAQ:ETON) investors has not been profitable (Simply Wall St.)
Jun-28-23 06:50AM	Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection (GlobeNewswire) -17.33%
May-16-23 11:35AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-11-23 05:35PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-10-23 06:50AM	Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution) (GlobeNewswire)
May-03-23 04:05PM	Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 (GlobeNewswire)
Apr-19-23 11:22AM	Getting In Cheap On Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Might Be Difficult (Simply Wall St.)
Mar-22-23 07:17AM	When Will Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Breakeven? (Simply Wall St.)
Mar-18-23 02:03AM	Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-16-23 05:25PM	Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Surpass Estimates (Zacks) +7.89%
04:01PM	Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results (GlobeNewswire)
Mar-15-23 06:50AM	Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600 (GlobeNewswire)
Mar-07-23 04:05PM	Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023 (GlobeNewswire)
Feb-08-23 12:00PM	Eton Pharmaceuticals, Inc. (ETON) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Feb-05-23 07:30AM	Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested three years ago (Simply Wall St.)
Jan-31-23 08:00AM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire)
Jan-25-23 10:00AM	Best Momentum Stocks to Buy for January 25th (Zacks)
07:21AM	New Strong Buy Stocks for January 25th (Zacks)
Jan-24-23 12:26PM	Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic (Zacks)
Jan-23-23 11:01AM	Amarin Corporation (AMRN) Down 13% in One Week: Here's Why (Zacks)
10:00AM	Best Momentum Stocks to Buy for January 23rd (Zacks)
07:36AM	New Strong Buy Stocks for January 23rd (Zacks)
Jan-12-23 10:34AM	ETON Up as FDA Accepts NDA for Dehydrated Alcohol Injection (Zacks) -5.41%
Jan-11-23 07:27AM	Etons stock rallies as FDA reviews treatment for alcohol poisoning (MarketWatch) +13.85%
06:50AM	Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection (GlobeNewswire)
Nov-23-22 12:37PM	Palisade Bio's (PALI) LB1148 Gets FDA Fast-Track Designation (Zacks)
Nov-22-22 12:45PM	bluebird bio (BLUE) Rides High on Its Gene Therapy Approvals (Zacks)
Nov-16-22 10:33AM	Arcutis (ARQT) Up on Top-Line Data From Atopic Dermatitis Study (Zacks)
05:34AM	Eton Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-10-22 05:45PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +19.92%
04:30PM	Edited Transcript of ETON.OQ earnings conference call or presentation 10-Nov-22 9:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-02-22 04:05PM	Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022 (GlobeNewswire)
Oct-18-22 04:05PM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire) -8.14%
06:50AM	Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference (GlobeNewswire)
Sep-27-22 09:05AM	60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago (ACCESSWIRE)
Sep-13-22 09:00AM	Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution (GlobeNewswire)
Aug-30-22 04:05PM	Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 05:35PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-08-22 10:00AM	Analysts Estimate Fortress Biotech (FBIO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Aug-04-22 10:00AM	Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: Should You Buy? (Zacks)
Aug-02-22 08:00AM	Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022 (GlobeNewswire)
Jul-18-22 08:09AM	Eton's stock gains 16% after announcing FDA approval of epilepsy drug (MarketWatch) +8.60%
07:05AM	Eton Pharmaceuticals Announces FDA Approval of ZONISADE (Zonisamide Oral Suspension) (GlobeNewswire)
Jun-24-22 09:45AM	Eton Pharma Shares Tick Higher After Offloading Hospital Products (Benzinga)
07:30AM	Eton Pharmaceuticals Announces Sale of Hospital Products (GlobeNewswire)
Jun-13-22 12:28PM	Eton Pharmaceuticals (NASDAQ:ETON) shareholders have endured a 62% loss from investing in the stock three years ago (Simply Wall St.)
May-13-22 09:08AM	Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Profit Outlook (Simply Wall St.) +7.61%
May-12-22 05:15PM	Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -5.86%
04:02PM	Eton Pharmaceuticals Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-10-22 05:45PM	Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-05-22 07:25PM	Cardiff Oncology (CRDF) Reports Q1 Loss, Misses Revenue Estimates (Zacks)

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Opaleye Management Inc.	10% Owner	Sep 10 '24	Buy	4.65	57,500	267,375	2,660,000	Sep 12 07:31 PM
Opaleye Management Inc.	10% Owner	Sep 11 '24	Buy	4.75	50,000	237,500	2,705,000	Sep 12 07:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ETON

Eton Pharmaceuticals Inc

Upgrade your FINVIZ experience